S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

G1 Therapeutics Short Interest Ratio and Short Volume

+0.12 (+0.59 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $20.43
50-Day Range
MA: $24.91
52-Week Range
Now: $20.43
Volume1.89 million shs
Average Volume1.78 million shs
Market Capitalization$857.22 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

G1 Therapeutics (NASDAQ:GTHX) Short Interest Data

Current Short Volume5,220,000 shares
Previous Short Volume5,380,000 shares
Change Vs. Previous Month:-2.97%
Dollar Volume Sold Short$115.36 million
Short Interest Ratio / Days to Cover3.2
Last Record DateFebruary, 12 2021
Outstanding Shares37,470,000 shares
Float Size27,970,000 shares
Short Percent of Float18.66%
Today's Trading Volume1,893,699 shares
Average Trading Volume1,781,337 shares
Today's Volume Vs. Average6.31%

Short Interest Over Time

G1 Therapeutics (NASDAQ:GTHX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/20215,220,000 shares $115.36 million -3.0%18.7%3.2 $22.10
1/29/20215,380,000 shares $163.01 million -10.8%19.4%3.8 $30.30
1/15/20216,030,000 shares $136.04 million -9.5%21.8%4.6 $22.56
12/31/20207,360,000 shares $138.22 million -2.9%26.3%6.1 $18.78
12/15/20207,360,000 shares $130.86 million -2.9%26.3%6.1 $17.78
11/30/20207,580,000 shares $147.96 million +14.2%27.1%6.6 $19.52
11/15/20206,640,000 shares $121.25 million -17.7%23.8%7.5 $18.26
10/30/20208,070,000 shares $103.13 million +8.0%28.8%10.4 $12.78
10/15/20207,470,000 shares $87.47 million +9.1%26.7%10.2 $11.71
9/30/20206,850,000 shares $90.90 million +39.5%24.5%9.9 $13.27
9/15/20204,910,000 shares $59.36 million +8.9%17.6%7.4 $12.09
8/31/20204,510,000 shares $71.12 million +3.2%16.1%7.4 $15.77
8/14/20204,370,000 shares $65.77 million +1.6%15.7%7 $15.05
7/31/20204,300,000 shares $70.35 million +19.8%15.5%7.1 $16.36
7/15/20203,590,000 shares $52.67 million +14.0%13.0%6.5 $14.67
6/30/20203,150,000 shares $55.25 million +2.9%11.4%6 $17.54
6/15/20203,060,000 shares $73.41 million No Change11.1%6.4 $23.99
5/29/20203,060,000 shares $70.81 million +6.3%11.1%6.5 $23.14
5/15/20202,880,000 shares $48.87 million +6.3%10.5%6.8 $16.97
4/30/20202,710,000 shares $48.89 million -3.2%9.8%7.4 $18.04
4/15/20202,800,000 shares $44.49 million -16.9%10.2%8.6 $15.89
3/31/20203,370,000 shares $44.89 million -2.7%12.3%10.6 $13.32
3/13/20203,463,100 shares $44.95 million -7.9%12.6%8.8 $12.98
2/28/20203,760,000 shares $40.12 million -3.3%13.7%12 $10.67
2/14/20203,890,000 shares $64.85 million -6.3%14.2%12.9 $16.67

G1 Therapeutics (NASDAQ:GTHX) Short Interest FAQ

speech bubbles
speech bubbles

What is G1 Therapeutics' current short interest?

Short interest is the volume of G1 Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 12th, investors have sold 5,220,000 shares of GTHX short. 18.66% of G1 Therapeutics' shares are currently sold short. View details.

What is a good short interest ratio for G1 Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. G1 Therapeutics currently has a short interest ratio of 3.0.

What is a good short interest percentage for G1 Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.66% of G1 Therapeutics' floating shares are currently sold short.

Is G1 Therapeutics' short interest increasing or decreasing?

G1 Therapeutics saw a decrease in short interest during the month of February. As of February 12th, there was short interest totaling 5,220,000 shares, a decrease of 3.0% from the previous total of 5,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is G1 Therapeutics' float size?

G1 Therapeutics currently has issued a total of 41,959,000 shares. Some of G1 Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. G1 Therapeutics currently has a public float of 27,970,000 shares.

How does G1 Therapeutics' short interest compare to its competitors?

18.66% of G1 Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to G1 Therapeutics: Agios Pharmaceuticals, Inc. (0.00%), FibroGen, Inc. (7.58%), Karuna Therapeutics, Inc. (8.08%), Legend Biotech Co. (2.25%), MorphoSys AG (0.00%), Alkermes plc (0.00%), Pacira BioSciences, Inc. (0.00%), Viela Bio, Inc. (7.97%), Rocket Pharmaceuticals, Inc. (0.00%), and Corcept Therapeutics Incorporated (10.33%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short G1 Therapeutics stock?

Short selling GTHX is an investing strategy that aims to generate trading profit from G1 Therapeutics as its price is falling. G1 Therapeutics' stock is trading up $0.12 today. To short G1 Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that G1 Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against G1 Therapeutics?

A short squeeze for G1 Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GTHX, which in turn drives the price of the stock up even further.

How often is G1 Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTHX, twice per month. The most recent reporting period available is February, 12 2021.

This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.